Experts at the Sarah Cannon Research Institute reflect on the groundbreaking advancements in cancer treatment and prevention made in 2024, particularly in lymphoma research. They highlight the growing use of immunotherapy, such as CAR T-cell therapy and bispecific antibodies, which offer more targeted and effective treatments with fewer side effects. Looking ahead to 2025, they predict continued improvements in curative treatment options for specific lymphoma types, with a focus on bringing these treatments closer to patients' homes.
At the beginning of 2024, the American Cancer Society predicted that 2,001,140 new cancer cases and 611,720 cancer deaths would occur in the United States. Now, as the year draws to a close, experts are looking back and reflecting on the discoveries and advances that have been made in the field of cancer treatment and prevention.
Q: How has the state of cancer in your specialty area changed and evolved over the past decade? A: In 2024, truly personalized medicine is possible, from mutation testing to direct targeted therapy to what a cancer needs to grow — as well as being able to provide many HR+ breast cancer patients with curative chemotherapy through personalized risk stratification assays.
Cancer Treatment Lymphoma Immunotherapy CAR T-Cell Therapy
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Tesla is recalling almost 700,000 vehicles due to a tire pressure monitoring system issueThe recall includes certain 2024 Cybertruck, 2017-2025 Model 3, and 2020-2025 Model Y vehicles.
Read more »
Oncologists Highlight 2024 Cancer Research Advances and 2025 PredictionsExperts reflect on the year's progress in cancer treatment and prevention, focusing on advancements in lymphoma research and the use of immunotherapy. Oncologists from the Sarah Cannon Research Institute discuss notable breakthroughs and future directions for cancer care.
Read more »
Bill Skarsgård's Rotten Tomatoes Cold Streak Is Officially Over Thanks To Acclaimed Upcoming Horror MovieBill Skarsgard in the posters for The Crow (2024), Boy Kills World (2024), and Nosferatu (2024)
Read more »
S&P 500: After a Memorable 2024, Could the Index Keep Rallying Into 2025?Stocks Analysis by Investing.com (Ismael De La Cruz) covering: FTSE 100, S&P 500, CAC 40, Dow Jones Industrial Average. Read Investing.com (Ismael De La Cruz)'s latest article on Investing.com
Read more »
Asia-Pacific Stocks Finish 2024 Strong, But 2025 Outlook Remains UncertainDespite a strong performance in 2024, driven by easing monetary policy and the AI boom, the outlook for Asia-Pacific markets in 2025 remains uncertain. While most major markets closed the year in positive territory, South Korea was the only exception, experiencing a significant decline. The direction of the U.S. and China's economies, along with the potential impact of the impeachment of South Korean President Yoon Suk Yeol, are key factors that will shape the region's performance next year.
Read more »
Grindrod outlines focus for 2025, reflects on 2024 performanceJSE-listed logistics company Grindrod, in a December 19 pre-closing trading update, said its focus going forward would be to drive growth in bulk handling, container handling, logistics capability and rail and transport, adding that demand for Grindrod's logistics service offering and its long-term business fundamentals remain strong.
Read more »